Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Syed Kamran Mahmood"'
Autor:
Raheel Iftikhar, Qamar un Nisa Chaudhry, Tariq Mehmood Satti, Syed Kamran Mahmood, Tariq Ghafoor, Ghassan Umair Shamshad, Nighat Shahbaz, Mehreen Ali Khan, Tariq Azam Khattak, Jahanzeb Rehman, Muhammad Farhan, Saima Humayun, Humera Haq, Syeda Ammaara Anwaar Naqvi, Faiz Anwer, Humayoon Shafique Satti, Parvez Ahmed
Publikováno v:
Clinical Hematology International, Vol 2, Iss 2 (2020)
Allogeneic stem cell transplant for high-risk aplastic anemia (AA) yields inferior results using conventional cyclophosphamide (CY)-based conditioning. The use of fludarabine (Flu)-based regimens has resulted in improved outcomes in high-risk patient
Externí odkaz:
https://doaj.org/article/d351dd7dd74c441297ae6d732ecfb695
Autor:
Raheel iftikhar, Qamar Un nisa Chaudhry, Tariq Mehmood Satti, Syed Kamran Mahmood, Tariq Ghafoor
Publikováno v:
Clinical Case Reports, Vol 7, Iss 7, Pp 1442-1444 (2019)
Key Clinical Message Post‐transplant lymphoproliferative disorders are rare but potentially life‐threatening complication of HSCT. Although not frequently reported but PTLD can occur as a late post‐transplant complication in HSCT recipients. A
Externí odkaz:
https://doaj.org/article/a592a9b8556a4e92be824b7a1bac52d1
Autor:
Jahanzeb Rehman, Mehreen Ali Khan, Nighat Shahbaz, Faiz Anwer, Muhammad Farhan, Parvez Ahmed, Tariq Azam Khattak, Saima Humayun, Ghassan Umair Shamshad, Qamar Un Nisa Chaudhry, Syed Kamran Mahmood, Ahsan Wahab, Amina Risalat, Raheel Iftikhar, Humayun Shafique Satti, Tariq Mehmood Satti, Tariq Ghafoor
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:2245-2251
Cyclosporine (CsA) combined with short-course methotrexate is considered standard-of-care graft-versus-host disease (GVHD) prophylaxis for patients with severe aplastic anemia (AA) who undergo transplantation using cyclophosphamide (Cy) plus anti-thy
Autor:
Nighat Shahbaz, Ghassan Umair Shamshad, Mehreen Ali Khan, Qamar Un Nisa Chaudhry, Abdul Rafae, Faiz Anwer, Jahanzeb Rehman, Raheel Iftikhar, Parvez Ahmed, Muhammad Farhan, Syed Kamran Mahmood, Fayyaz Hussain, Sundas Ali, Zunaira Shah, Tariq Azam Khattak, Maryam Khan, Tariq Ghafoor
Publikováno v:
Bone Marrow Transplantation. 56:863-872
Management of rare hematological disorders pose unique diagnostic and therapeutic challenges due to unusual occurrence and limited treatment options. We retrospectively identified 45 patients receiving matched related donor transplant for rare hemato
Autor:
Tariq Mehmood Satti, Mehreen Ali Khan, Qamar-Un-Nisa Chaudhry, Tariq Ghafoor, Nadia Sial, Zaineb Akram, Parvez Ahmed, Nighat Shahbaz, Humayoon Shafique Satti, Salman Akbar Malik, Syed Kamran Mahmood
Publikováno v:
Regenerative Engineering and Translational Medicine. 7:234-243
Mesenchymal stromal cells (MSCs) have emerged as a promising candidate for the treatment of steroid-refractory graft-versus-host disease (GVHD). In this uncontrolled, pilot clinical study, we report safety and efficacy of allogeneic bone marrow MSCs
Autor:
Parvez Ahmed, Mehreen Ali Khan, Zaineb Akram, Syed Kamran Mahmood, Tariq Mahmood Satti, Qamar Un Nisa Chaudhry, Nighat Shahbaz, Raheel Iftikhar, Humayoon Shafique Satti, Tariq Ghafoor
Publikováno v:
Hematology. 25:48-54
Objective: Prevalence of aplastic anemia (AA) is high in the Asian population. This study was done to explore the etiology and association of AA with various socio-economic and environmental factor...
Autor:
Tariq Ghafoor, Mehreen Ali Khan, Muhammad Farhan, Humayoon Shafique Satti, Faiz Anwer, Tariq Mehmood Satti, Parvez Ahmed, Qamar Un Nisa Chaudhry, Ghassan Umair Shamshad, Syed Kamran Mahmood, Nighat Shahbaz, Tariq Azam Khattak, Saima Humayun, Jahanzeb Rehman, Raheel Iftikhar
Publikováno v:
Biology of Blood and Marrow Transplantation. 25:2375-2382
Despite excellent transplant outcomes of aplastic anemia (AA) in developed countries, management in developing countries is challenging because of delay in the diagnosis, use of family donors for transfusions, and higher infection risk pretransplant.
Autor:
Tariq Mehmood Satti, Jahanzeb Rehman, Nighat Shahbaz, Ghassan Umair Shamshad, Mehreen Ali Khan, Raheel Iftikhar, Tariq Ghafoor, Syed Kamran Mahmood, Tariq Azam Khattak, Muhammad Farhan, Parvez Ahmed, Qamar Un Nisa Chaudhry
Publikováno v:
Bone marrow transplantation. 56(9)
Introduction Allogeneic hematopoietic stem cell transplant (HSCT) is the standard treatment for patients younger than 40 years with Severe and Very Severe Aplastic Anemia (AA) who have a Matched Related Donor (MRD). For patients lacking a MRD, treatm
Autor:
Ghassan Umair Shamshad, Saima Humayun Toor, Jahanzeb Rehman, Syed Kamran Mahmood, Raheel Iftikhar, Tariq Mahmood Satti
Publikováno v:
Journal of the College of Physicians and Surgeons--Pakistan : JCPSP. 30(5)
Objective To compare the efficacy and side effect profile of different bortezomib-based triplet regimens for remission induction in patients with multiple myeloma (MM). Study design Observational study. Place and duration of study Armed Forces Bone M
Autor:
Tariq Ghafoor, Raheel Iftikhar, Syed Kamran Mahmood, Qamar Un Nisa Chaudhry, Tariq Mehmood Satti
Publikováno v:
Clinical Case Reports, Vol 7, Iss 7, Pp 1442-1444 (2019)
Clinical Case Reports
Clinical Case Reports
Post‐transplant lymphoproliferative disorder (PTLD) is rarely reported in matched sibling donor (MSD) transplants of aplastic anemia (AA), and occurrence of Hodgkin lymphoma in this subgroup is extremely uncommon. Our patient, a 7‐year‐old girl